Periodic Continuous Glucose Monitoring in Patients With Type 2 Diabetes
Recruiting · NCT05633628 · Interventional (participants receive a specific treatment) · Lead sponsor: Sophiahemmet University
View the official record on ClinicalTrials.gov →Interventions studied
Periodic CGM group with data analysis report- Intervention group
What this trial is about
The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adults aged 18-80 years
- Type 2 diabetes with a duration of \> 6 months
- HbA1c 45-70 mmol/mol
- Have a smartphone
- Experience of self-monitoring of blood glucose prior to the study start
Exclusion criteria
- Prandial insulin
- Pregnancy or planning pregnancy during the study
- Breastfeeding
- Renal disease with estimated glomerular filtration rate (eGFR) \<45 mL/ min/1.73 m2
- Active malignancy or under investigation for malignancy
- Severe visual impairment
- Severe skin allergy that inhibits the use of a continuous glucose monitoring device
- Glucocorticoids (systemic)
- Planned or currently using weight reduction medications, programs, or surgery
- Cognitively or psychologically unable to participate and read instructions
- Enrolled in other clinical trials
- Eating disorders
Where it is running
1 location listed.
- Sophiahemmet University - Stockholm, Sweden